Vir Biotechnology (VIR) Price to Sales (2019 - 2026)
Vir Biotechnology's (VIR) Price to Sales was 5.68 for Q2 2026, down 84.6% from 36.84 a year earlier and down 74.2% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Price to Sales (2019 - 2026) Analysis & Trends
For FY2025, Price to Sales at Vir Biotechnology was 12.27, down 9.4% from FY2024.
- By year, Price to Sales came in at 13.55 in FY2024 (-13.9%), 15.73 in FY2023 (+653.9%), 2.09 in FY2022 (-58.4%) and 5.01 in FY2021 (-88.8%).
- The Q2 2026 figure ranks as the lowest quarterly Price to Sales since Q4 2022.
- Year over year, Price to Sales has now declined in each of the last three quarters, with growth averaging 51.9% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q3 2023 (growth of 917.6%); the low point was Q1 2022 (a decline of 98.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 22.04 (Q1 2026), 12.27 (Q4 2025) and 47.08 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.68 |
| Mar 31, 2026 | 22.04 |
| Dec 31, 2025 | 12.27 |
| Sep 30, 2025 | 47.08 |
| Jun 30, 2025 | 36.84 |
| Mar 31, 2025 | 42.89 |
| Dec 31, 2024 | 13.55 |
| Sep 30, 2024 | 13.02 |
| Jun 30, 2024 | 15.41 |
| Mar 31, 2024 | 17.29 |
| Dec 31, 2023 | 15.73 |
| Sep 30, 2023 | 10.61 |
| Jun 30, 2023 | 6.71 |
| Mar 31, 2023 | 5.91 |
| Dec 31, 2022 | 1.99 |
| Sep 30, 2022 | 1.04 |
| Jun 30, 2022 | 1.54 |
| Mar 31, 2022 | 1.46 |
| Dec 31, 2021 | 5.01 |
| Sep 30, 2021 | 20.02 |
API Access
Vir Biotechnology Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();